GoHealth (NASDAQ:GOCO) Announces Earnings Results

Posted by on May 20th, 2026

GoHealth (NASDAQ:GOCO – Get Free Report) released its quarterly earnings results on Monday. The company reported ($2.36) EPS for the quarter, beating analysts’ consensus estimates of ($2.40) by $0.04, FiscalAI reports. The business had revenue of $11.91 million during the quarter, compared to analyst estimates of $16.90 million. GoHealth had a negative return on equity of 33.29% and a negative net margin of 71.06%.

GoHealth Trading Down 13.0%

Shares of GoHealth stock opened at $0.75 on Wednesday. The firm has a market capitalization of $21.64 million, a P/E ratio of -0.04 and a beta of 1.33. The business has a fifty day simple moving average of $1.28 and a two-hundred day simple moving average of $2.03. GoHealth has a 12 month low of $0.72 and a 12 month high of $7.12.

Hedge Funds Weigh In On GoHealth

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its position in GoHealth by 22.8% during the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock valued at $105,000 after buying an additional 1,452 shares during the period. Bridgeway Capital Management LLC lifted its position in GoHealth by 8.2% during the second quarter. Bridgeway Capital Management LLC now owns 27,066 shares of the company’s stock valued at $150,000 after buying an additional 2,058 shares during the period. Geode Capital Management LLC lifted its position in GoHealth by 4.3% during the second quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock valued at $660,000 after buying an additional 4,955 shares during the period. Charles Schwab Investment Management Inc. lifted its position in GoHealth by 119.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after buying an additional 14,388 shares during the period. Finally, Redwood Capital Management LLC purchased a new position in GoHealth during the third quarter valued at $4,455,000. Hedge funds and other institutional investors own 24.21% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Freedom Capital downgraded shares of GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of GoHealth in a research report on Friday, April 24th. Finally, Noble Financial raised shares of GoHealth to a “strong-buy” rating in a research report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $5.00.

Check Out Our Latest Report on GoHealth

About GoHealth

(Get Free Report)

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.

Read More

Earnings History for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.